The impact of CBP expression in estrogen receptor-positive breast cancer

被引：0
作者：
Wafaa S. Ramadan
Iman M. Talaat
Mahmood Y. Hachim
Annette Lischka
Timo Gemoll
Raafat El-Awady
机构：
[1] University of Sharjah,Sharjah Institute for Medical Research
[2] University of Sharjah,College of Medicine
[3] University of Alexandria,Department of Pathology, Faculty of Medicine
[4] Mohammed Bin Rashid University of Medicine and Health Sciences,College of Medicine
[5] University of Lübeck and University Hospital Schleswig-Holstein,Section for Translational Surgical Oncology and Biobanking, Department of Surgery
[6] University of Sharjah,College of Pharmacy
来源：
Clinical Epigenetics | 2021年 / 13卷
关键词：
Breast cancer; CBP; GCN5; ERα; HER2; Luminal subtypes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 139 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Akram M(2017)Awareness and current knowledge of breast cancer Biol Res 50 33-2020
[3]  
Iqbal M(2014)Delay in breast cancer: implications for stage at diagnosis and survival Front Public Health 2 87-343
[4]  
Daniyal M(2019)Global trend of breast cancer mortality rate: a 25-year study Asian Pac J Cancer Prev 20 2015-513
[5]  
Khan AU(2016)Classification, treatment strategy, and associated drug resistance in breast cancer Clin Breast Cancer 16 335-8177
[6]  
Caplan L(2020)Overcoming endocrine resistance in breast cancer Cancer Cell 37 496-175
[7]  
Azamjah N(2020)Chemotherapy resistance and stromal targets in breast cancer treatment: a review Mol Biol Rep 47 8169-35
[8]  
Soltan-Zadeh Y(2018)Progress in targeted therapy for breast cancer Chronic Dis Transl Med 4 164-243
[9]  
Zayeri F(2014)Molecular markers for breast cancer: prediction on tumor behavior Dis Mark 2014 513158-23
[10]  
Tang Y(2018)Epigenetics of breast cancer: biology and clinical implication in the era of precision medicine Semin Cancer Biol 51 22-196
12345678910